Samorita Hospital Income Statement

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	430.3	401.37	378.39	334.27	338.09	393.62
Revenue Growth (YoY)	14.77%	6.07%	13.20%	-1.13%	-14.11%	22.53%
Cost of Revenue	183.92	177.07	162.67	145.76	148.05	172.75
Gross Profit	246.39	224.29	215.72	188.5	190.04	220.87
Selling, General & Admin	192.8	181.38	170.38	157.9	141.97	147.25
Other Operating Expenses	0.8	0.8	0.82	1.87	0.64	0.12
Operating Expenses	218.34	207.39	198.15	184.72	165.63	171.7
Operating Income	28.04	16.9	17.57	3.78	24.41	49.17
Interest Expense	-2.34	-2.76	-5.44	-6.05	-6.93	-
Interest & Investment Income	1.6	1.36	2.08	2.44	3.67	4.04
Earnings From Equity Investments	0.11	0.1	0.04	0.04	0.04	-0.07
Other Non Operating Income (Expenses)	2.76	2.68	2.48	2.86	2.84	1.46
EBT Excluding Unusual Items	30.17	18.27	16.73	3.07	24.03	54.61
Gain (Loss) on Sale of Assets	-0.23	-0.23	0.18	0.03	0.31	-0.07
Pretax Income	29.95	18.05	16.92	3.1	24.34	54.53
Income Tax Expense	11.42	4.52	4.72	2.38	8.04	12.44
Net Income	18.53	13.53	12.2	0.72	16.29	42.09
Net Income to Common	18.53	13.53	12.2	0.72	16.29	42.09
Net Income Growth	226.36%	10.91%	1593.40%	-95.58%	-61.29%	1193.89%
Shares Outstanding (Basic)	22	22	22	22	22	22
Shares Outstanding (Diluted)	22	22	22	22	22	22
EPS (Basic)	0.85	0.62	0.56	0.03	0.75	1.93
EPS (Diluted)	0.85	0.62	0.56	0.03	0.75	1.93
EPS Growth	226.36%	10.91%	1593.42%	-95.58%	-61.29%	1193.89%
Free Cash Flow	27.68	16.41	26.65	-0.04	-11.26	-21.62
Free Cash Flow Per Share	1.27	0.75	1.22	-0.00	-0.52	-0.99
Dividend Per Share	0.500	0.500	0.500	-	0.433	0.866
Dividend Growth	-	-	-	-	-50.00%	-
Gross Margin	57.26%	55.88%	57.01%	56.39%	56.21%	56.11%
Operating Margin	6.52%	4.21%	4.64%	1.13%	7.22%	12.49%
Profit Margin	4.30%	3.37%	3.22%	0.22%	4.82%	10.69%
Free Cash Flow Margin	6.43%	4.09%	7.04%	-0.01%	-3.33%	-5.49%
EBITDA	51.91	40.9	41.22	26.82	44.27	69.81
EBITDA Margin	12.06%	10.19%	10.89%	8.02%	13.09%	17.74%
D&A For EBITDA	23.87	24	23.65	23.04	19.86	20.64
EBIT	28.04	16.9	17.57	3.78	24.41	49.17
EBIT Margin	6.52%	4.21%	4.64%	1.13%	7.22%	12.49%
Effective Tax Rate	38.14%	25.02%	27.88%	76.76%	33.06%	22.82%
Advertising Expenses	-	0.77	1.03	1.02	0.93	1.01

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.